Atom Investors LP Rhythm Pharmaceuticals, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $518,650 - $649,887	-14,647 Reduced 35.49%	26,629 $1.09 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $639,416 - $857,131	16,345 Added 65.56%	41,276 $1.79 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $118,607 - $275,253	5,545 Added 28.6%	24,931 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $306,492 - $538,930	19,386 New	19,386 $444,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.34B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.